Bellerophon Therapeutics

Region Nordamerika
ISIN US0787713009
Sektor Medizintechnik, Biotech
Website https://bellerophon.com/

Bellerophon is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases.

Artikel über Bellerophon Therapeutics

Titel Autor Datum
NO to COVID!
rotten.tom vor 7 Tagen